The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 6462 of April 21, 2021, Tuscany Regional Healthcare has published assessments of six medical devices of various therapeutic areas, including devices for the treatment of vaginal prolapse, cardiovascular conditions, an implant for vocal cord rehabilitation, and a cerebral embolic protective device.
Below is the list of technologies that have been assessed:
- Surelift System for the treatment of vaginal prolapse
- TENDYNE™ mitral valve system
- UrgoClean Ag dressing
- KONAR-MF VSD Occluder (percutaneous transcatheter occlusion device)
- Vox Implant for vocal cord rehabilitation
- TriGUARD 3 ™ (cerebral embolic protective device)
See the regional decree and all assessments in Italian here or here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.